Business Wire

CA-NETAPP

Share
Aston Martin Aramco Formula One® Team and NetApp Renew Partnership

The Aston Martin Aramco Formula One® Team and NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced the renewal of their partnership, designating NetApp as the team’s Global Data Infrastructure Partner. NetApp has been a key partner to the team since it returned to Formula One® racing in 2021 after more than 60 years away from the track. This partnership renewal builds on the previous three years of successful collaboration, empowering Aston Martin Aramco to use NetApp’s storage technology to instantly store, manage, and access the immense amounts of data the team needs to optimize its performance.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240205989417/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Clare Lansley (left), CIO of Aston Martin Aramco and George Kurian (right), CEO of NetApp, shake hands to celebrate their companies’ partnership renewal. (Photo: Business Wire)

Data gives Formula One® drivers and their support teams the insights they need to make the right decisions to optimize their race performance. Data powers simulations that help teams predict and respond to scenarios that might occur during a race such as changing weather conditions or an unplanned pit stop. Using data to understand the impact of these situations in advance enables them to adapt in real-time in a race where milliseconds matter. Without those insights, the teams might not make a decision about how to respond before the opportunity has passed by. During any race, the Aston Martin Aramco team collects data from hundreds of sensors, including real-time performance statistics such as track temperature, tire degradation, and aerodynamics. Instant access to that data, both trackside and at the team’s state-of-the-art AMR Technology Campus (AMRTC), gives the team the data it needs to adapt its race strategy in real-time. Since sharing data between the track and team headquarters plays such a central role in the team’s success, data storage and management is a mission-critical function.

“We are delighted to renew our partnership with NetApp as we enter our fourth season together since returning to Formula One in 2021,” said Clare Lansley, CIO of Aston Martin Aramco. “NetApp has been with us all the way on this journey together and are fundamental to our trackside operations and at our Headquarters at the AMRTC in Silverstone. We use data to improve our performance and go faster and NetApp’s work with the team is vital to this success.”

By leveraging the data NetApp stores and manages, the Aston Martin Aramco team reached the podium eight times, scored 280 points, and finished fifth in the Constructors’ Championship in the 2023 Formula One® season. By having NetApp as its Global Data Infrastructure Partner, the team will receive continued support for its data storage and analysis including:

  • Speed: The NetApp FlexPod® data center solution helps the team instantly access and store immense amounts of data, transferring data quickly and efficiently between trackside, race headquarters, and the factory to enable near-real time decisions that affect race strategy.
  • Reliability: NetApp® Cloud Volumes ONTAP® ensures enterprise reliability and continuous operations in case of failures, so the team’s data is always there when it needs it.
  • Observability: NetApp® Cloud Insights makes it easy for the team to monitor, troubleshoot, and optimize all its resources and applications so it can efficiently adopt and operate new technology both on premises and in the cloud, providing full-stack observability.
  • Security: NetApp® Storage Workload Security provides continuous protection against both insider and external threats by monitoring and protecting the data held on the NetApp platform.
  • Scalability: The entire NetApp solution can scale and grow so the team can rise to any challenge even as its IT requirements grow and change.

“NetApp and the Aston Martin Aramco team are well matched as partners because we are both dedicated to the pursuit of breakthrough performance and true innovation,” said Gabie Boko, Chief Marketing Officer at NetApp. “When Aston Martin returned to the Formula One® circuit after more than 60 years away, they needed a technology partner to help them rise to every moment, both on and off the track. NetApp provides Aston Martin Aramco with an intelligent data infrastructure that runs at the speed of Formula One®.”

The sheer speed at which Aston Martin Aramco can harness its stored data gives it a clear competitive advantage. NetApp data solutions enable the team to fuel its relentless pursuit of innovation as it designs faster vehicles and optimizes its race strategy.

Additional Resources

About NetApp

NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205989417/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye